Bristol Myers Squibb

E560549

biopharmaceutical company public company

Bristol Myers Squibb is a global biopharmaceutical company known for developing and manufacturing innovative medicines in areas such as oncology, immunology, and cardiovascular disease.

Try in SPARQL Jump to: Surface forms Disambiguation Statements Elicitation Referenced by

All labels observed (2)

Label	Occurrences
Bristol Myers Squibb canonical	5
Bristol-Myers Squibb	5

How this entity was disambiguated

This entity first appeared as the object of triple T5999480 — resolving that mention is where its identity was fixed. The disambiguator weighed these candidate entities and picked the highlighted one (or “None”, minting a new entity). This is how homonymy is resolved: the same surface form can point to different entities.

NED1 Entity disambiguation (via context triple) gpt-5-mini-2025-08-07

Target entity: Bristol Myers Squibb
Context triple: [Bristol-Myers Squibb offices (Plainsboro Township), partOf, Bristol Myers Squibb]

A. Merck & Co.
Merck & Co. is a major American pharmaceutical company known for developing and producing vaccines, oncology drugs, and other innovative medicines.
B. Pharmaceutical Research and Manufacturers of America
Pharmaceutical Research and Manufacturers of America is a major U.S. trade association representing leading biopharmaceutical and drug research companies.
C. Pfizer
Pfizer is a major American multinational pharmaceutical and biotechnology corporation known for developing a wide range of prescription medicines and vaccines, including one of the first widely used COVID-19 vaccines.
D. Novartis
Novartis is a global Swiss-based pharmaceutical company known for developing innovative medicines across a wide range of therapeutic areas.
E. Janssen Pharmaceuticals
Janssen Pharmaceuticals is a global pharmaceutical company, part of Johnson & Johnson, known for developing and marketing a wide range of prescription medicines across areas such as immunology, oncology, neuroscience, and cardiovascular disease.
F. None of above. chosen
G. Unsure - the case is ambiguous/there is not enough information to decide.

NED2 Entity disambiguation (via description) gpt-5-mini-2025-08-07

Target entity: Bristol Myers Squibb
Target entity description: Bristol Myers Squibb is a global biopharmaceutical company known for developing and manufacturing innovative medicines in areas such as oncology, immunology, and cardiovascular disease.

A. Merck & Co.
Merck & Co. is a major American pharmaceutical company known for developing and producing vaccines, oncology drugs, and other innovative medicines.
B. Pharmaceutical Research and Manufacturers of America
Pharmaceutical Research and Manufacturers of America is a major U.S. trade association representing leading biopharmaceutical and drug research companies.
C. Pfizer
Pfizer is a major American multinational pharmaceutical and biotechnology corporation known for developing a wide range of prescription medicines and vaccines, including one of the first widely used COVID-19 vaccines.
D. Novartis
Novartis is a global Swiss-based pharmaceutical company known for developing innovative medicines across a wide range of therapeutic areas.
E. Janssen Pharmaceuticals
Janssen Pharmaceuticals is a global pharmaceutical company, part of Johnson & Johnson, known for developing and marketing a wide range of prescription medicines across areas such as immunology, oncology, neuroscience, and cardiovascular disease.
F. None of above. chosen

Statements (50)

Predicate	Object
instanceOf	biopharmaceutical company ⓘ public company ⓘ
acquired	Celgene NERFINISHED ⓘ
acquisitionDate	2019 ⓘ
country	United States of America ⓘ surface form: United States
develops	biologic therapies ⓘ cell therapies ⓘ immuno-oncology drugs ⓘ prescription medicines ⓘ
engagesIn	clinical trials ⓘ research and development ⓘ
focusesOnTherapeuticArea	cardiovascular disease ⓘ fibrosis ⓘ hematology ⓘ immunology ⓘ oncology ⓘ
formedByMergerOf	Bristol-Myers Company NERFINISHED ⓘ Squibb Corporation NERFINISHED ⓘ
foundedBy	Edward Robinson Squibb NERFINISHED ⓘ John Ripley Myers NERFINISHED ⓘ William McLaren Bristol NERFINISHED ⓘ
hasAbbreviation	BMS NERFINISHED ⓘ
hasISIN	US1101221083 ⓘ
hasNumberOfEmployees	over 30,000 ⓘ
hasOfficialWebsite	https://www.bms.com ⓘ
hasTickerSymbol	BMY NERFINISHED ⓘ
headquartersLocation	New York NERFINISHED ⓘ New York City ⓘ United States of America ⓘ surface form: United States
inception	1989 ⓘ
industry	biopharmaceuticals ⓘ biotechnology ⓘ pharmaceuticals ⓘ
listedOn	New York Stock Exchange ⓘ
operatesIn	Africa ⓘ Asia ⓘ Europe ⓘ Latin America ⓘ Middle East ⓘ North America ⓘ
product	Abecma NERFINISHED ⓘ Breyanzi NERFINISHED ⓘ Eliquis NERFINISHED ⓘ Opdivo NERFINISHED ⓘ Orencia NERFINISHED ⓘ Pomalyst NERFINISHED ⓘ Revlimid NERFINISHED ⓘ Sprycel NERFINISHED ⓘ Yervoy NERFINISHED ⓘ
tradedAs	NYSE:BMY NERFINISHED ⓘ

How these facts were elicited

Referenced by (10)

Full triples — surface form annotated when it differs from this entity's canonical label.

Bristol-Myers Squibb offices → partOf → Bristol Myers Squibb ⓘ

subject surface form: Bristol-Myers Squibb offices (Plainsboro Township)

Bristol-Myers Squibb offices → ownedBy → Bristol Myers Squibb ⓘ

subject surface form: Bristol-Myers Squibb offices (Plainsboro Township)

Bristol-Myers Squibb offices → operator → Bristol Myers Squibb ⓘ

subject surface form: Bristol-Myers Squibb offices (Plainsboro Township)

Bristol-Myers Squibb offices → affiliation → Bristol Myers Squibb ⓘ

subject surface form: Bristol-Myers Squibb offices (Plainsboro Township)

Zimmer Holdings → parentCompany → Bristol Myers Squibb ⓘ